L. M. Nardozza, A. C. Caetano, A. C. Zamarian, J. B. Mazzola, and C. P. Silva, Fucose, placental evolution and the glycocode, vol.22, p.211, 2012.

P. Hadlock, R. B. Harrist, R. S. Sharman, R. L. Deter, and S. K. Park, Estimation of 213 fetal weight with the use of head, body and femur measurements-a prospective 214 study, Am. J Obstet. Gynecol, vol.151, pp.333-340, 1985.

A. Lausman and J. Kingdom, Maternal Fetal Medicine Committee, Intrauterine 216 growth restriction: screening, diagnosis and management, J Obstet. Gynaecol

, Can, vol.35, pp.741-57, 2013.

, American College of Obstetricians and Gynecologists, ACOG Practice bulletin 219 no. 134: fetal growth restriction, Obstet. Gynecol, vol.121, pp.1122-1155, 2013.

F. Figueras and E. Gratacós, Update on the Diagnosis and Classification of Fetal 221

, Growth Restriction and Proposal of a Stage-Based Management Protocol, Fetal 222 Diagn. Ther, vol.36, pp.86-98, 2014.

T. R. Fenton, R. Nasser, M. Eliasziw, J. H. Kim, D. Bilan et al., Validating 224 the weight gain of preterm infants between the reference growth curve of the 225 fetus and the term infant, BMC Pediatr, vol.13, p.227, 2013.

R. E. Cunningham, Tissue Microarrays: Construction and Uses, Methods in 228 molecular biology, vol.724, pp.23-35, 2011.

A. Breiman, M. D. Robles, S. C. Trécesson, and K. Echasserieau, , p.230

K. Bernardeau, K. Drickamer, A. Imberty, S. Barillé-nion, F. Altare et al., Le Highlights ? Placental endothelial glycocalyx fucosylation was studied in terminal and stem villi

, ? Fucosylated type 2 glycans changes may reflect alterations of villi in FGR

?. Eo-, FGR differs from LO-FGR by a markedly increased Le Y expression

, ? Expression patterns of fucosylated glycans may reflect placental glycopathology in FGR